col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: Cell
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―27 Emergence of an early SARS-CoV-2 epidemic in the United States Mark Zeller, Karthik Gangavarapu, Catelyn Anderson, Allison R. Smither, John A. Vanchiere, Rebecca Rose, et al. (+46)
2 [GO] 2021―Jul―23 Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 Carly G.K. Ziegler, Vincent N. Miao, Anna H. Owings, Andrew W. Navia, Ying Tang, Joshua D. Bromley, et al. (+19)
3 [GO] 2021―Jul―23 Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike Pei Tong, Avneesh Gautam, Ian W. Windsor, Meghan Travers, Yuezhou Chen, Nicholas Garcia, et al. (+27)
4 [GO] 2021―Jul―07 A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation Lin Kang, Guijuan He, Amanda K. Sharp, Xiaofeng Wang, Anne M. Brown, Pawel Michalak, James Weger-Lucarelli
5 [GO] 2021―Jun―30 Structure-guided T cell vaccine design for SARS-CoV-2 variants and sarbecoviruses Anusha Nathan, Elizabeth J. Rossin, Clarety Kaseke, Ryan J. Park, Ashok Khatri, Dylan Koundakjian, et al. (+13)
6 [GO] 2021―Jun―18 In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies Dapeng Li, Robert J. Edwards, Kartik Manne, David R. Martinez, Alexandra Schäfer, S. Munir Alam, et al. (+58)
7 [GO] 2021―Jun―17 Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum Chang Liu, Helen M. Ginn, Wanwisa Dejnirattisai, Piyada Supasa, Beibei Wang, Aekkachai Tuekprakhon, et al. (+53)
8 [GO] 2021―Jun―09 Identification of novel bat coronaviruses sheds light on the evolutionary origins of SARS-CoV-2 and related viruses Hong Zhou, Jingkai Ji, Xing Chen, Yuhai Bi, Juan Li, Qihui Wang, et al. (+9)
9 [GO] 2021―Jun―08 SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD and S2 Fatima Amanat, Mahima Thapa, Tinting Lei, Shaza M. Sayed Ahmed, Daniel C. Adelsberg, Juan Manuel Carreno, et al. (+16)
10 [GO] 2021―Jun―05 The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies Richard Copin, Alina Baum, Elzbieta Wloga, Kristen E. Pascal, Stephanie Giordano, Benjamin O. Fulton, et al. (+31)
11 [GO] 2021―Jun―03 Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs Shira Weingarten-Gabbay, Susan Klaeger, Siranush Sarkizova, Leah R. Pearlman, Da-Yuan Chen, Kathleen M.E. Gallagher, et al. (+34)
12 [GO] 2021―Jun―01 Low-Dose Ad26.COV2.S Protection Against SARS-CoV-2 Challenge in Rhesus Macaques Xuan He, Abishek Chandrashekar, Roland Zahn, Frank Wegmann, Jingyou Yu, Noe B. Mercado, et al. (+27)
13 [GO] 2021―May―26 Tackling COVID-19 with neutralizing monoclonal antibodies Davide Corti, Lisa A. Purcell, Gyorgy Snell, David Veesler
14 [GO] 2021―May―24 Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE-2 in humans and other species Kefang Liu, Xiaoqian Pan, Linjie Li, Feng Yu, Anqi Zheng, Pei Du, et al. (+18)
15 [GO] 2021―May―24 Coupling of N7-methyltransferase and 3'-5' exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading Liming Yan, Yunxiang Yang, Mingyu Li, Ying Zhang, Litao Zheng, Ji Ge, et al. (+10)
16 [GO] 2021―May―24 An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies Yafei Liu, Wai Tuck Soh, Jun-ichi Kishikawa, Mika Hirose, Emi E. Nakayama, Songling Li, et al. (+31)
17 [GO] 2021―May―04 High resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies Meghan E. Garrett, Jared Galloway, Helen Y. Chu, Hannah L. Itell, Caitlin I. Stoddard, Caitlin R. Wolf, et al. (+5)
18 [GO] 2021―Apr―29 SARS-CoV-2 RNA: Exclusive friends and common foes Emmanuelle V. LeBlanc, Che C. Colpitts
19 [GO] 2021―Apr―29 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Wilfredo F. Garcia-Beltran, Evan C. Lam, Kerri St. Denis, Adam D. Nitido, Zeidy H. Garcia, Blake M. Hauser, et al. (+9)
20 [GO] 2021―Apr―24 B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV Johannes F. Scheid, Christopher O. Barnes, Basak Eraslan, Andrew Hudak, Jennifer R. Keeffe, Lisa A. Cosimi, et al. (+30)
21 [GO] 2021―Apr―24 Structural insight into SARS-CoV-2 neutralizing antibodies and modulation of syncytia Daniel Asarnow, Bei Wang, Wen-Hsin Lee, Yuanyu Hu, Ching-Wen Huang, Bryan Faust, et al. (+25)
22 [GO] 2021―Apr―21 Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant Xianding Deng, Miguel A. Garcia-Knight, Mir M. Khalid, Venice Servellita, Candace Wang, Mary Kate Morris, et al. (+40)
23 [GO] 2021―Apr―03 Early introductions and transmission of SARS-CoV-2 variant B.1.1.7 in the United States Tara Alpert, Anderson F. Brito, Erica Lasek-Nesselquist, Jessica Rothman, Andrew L. Valesano, Matthew J. MacKay, et al. (+44)
24 [GO] 2021―Mar―30 Antibody evasion by the P.1 strain of SARS-CoV-2 Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, Chang Liu, Alexander J. Mentzer, Helen M. Ginn, et al. (+45)
25 [GO] 2021―Mar―30 Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States Nicole L. Washington, Karthik Gangavarapu, Mark Zeller, Alexandre Bolze, Elizabeth T. Cirulli, Kelly M. Schiabor Barrett, et al. (+48)
26 [GO] 2021―Mar―30 TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Jessica Sook Yuin Ho, Bobo Wing-Yee Mok, Laura Campisi, Tristan Jordan, Soner Yildiz, Sreeja Parameswaran, et al. (+47)
27 [GO] 2021―Mar―20 SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies Markus Hoffmann, Prerna Arora, Rüdiger Groß, Alina Seidel, Bojan F. Hörnich, Alexander S. Hahn, et al. (+13)
28 [GO] 2021―Mar―18 N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 Matthew McCallum, Anna De Marco, Florian A. Lempp, M. Alejandra Tortorici, Dora Pinto, Alexandra C. Walls, et al. (+28)
29 [GO] 2021―Mar―18 Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein Naveenchandra Suryadevara, Swathi Shrihari, Pavlo Gilchuk, Laura A. VanBlargan, Elad Binshtein, Seth J. Zost, et al. (+13)
30 [GO] 2021―Mar―18 SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms Sarah A. Clark, Lars E. Clark, Junhua Pan, Adrian Coscia, Lindsay G.A. McKay, Sundaresh Shankar, et al. (+7)
31 [GO] 2021―Mar―18 BET Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV-2 Infection Richard J. Mills, Sean J. Humphrey, Patrick RJ. Fortuna, Mary Lor, Simon R. Foster, Gregory A. Quaife-Ryan, et al. (+40)
32 [GO] 2021―Mar―12 Discovery and functional interrogation of SARS-CoV-2 RNA-host protein interactions Ryan A. Flynn, Julia A. Belk, Yanyan Qi, Yuki Yasumoto, Jin Wei, Mia Madel Alfajaro, et al. (+13)
33 [GO] 2021―Mar―12 Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity Wilfredo F. Garcia-Beltran, Evan C. Lam, Kerri St. Denis, Adam D. Nitido, Zeidy H. Garcia, Blake M. Hauser, et al. (+9)
34 [GO] 2021―Mar―02 Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system Man Lung Yeung, Jade Lee Lee Teng, Lilong Jia, Chaoyu Zhang, Chengxi Huang, Jian-Piao Cai, et al. (+16)
35 [GO] 2021―Feb―23 Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Emanuele Andreano, Emanuele Nicastri, Ida Paciello, Piero Pileri, Noemi Manganaro, Giulia Piccini, et al. (+29)
36 [GO] 2021―Feb―23 No higher infectivity but immune escape of SARS-CoV-2 501Y.V2 variants Qianqian Li, Jianhui Nie, Jiajing Wu, Li Zhang, Ruxia Ding, Haixin Wang, et al. (+21)
37 [GO] 2021―Feb―23 A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence Xianwen Zhang, Yang Liu, Jianying Liu, Adam L. Bailey, Kenneth S. Plante, Jessica A. Plante, et al. (+10)
38 [GO] 2021―Feb―23 Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine induced sera Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, Chang Liu, Alexander J. Mentzer, Helen M. Ginn, et al. (+38)
39 [GO] 2021―Feb―18 Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, Chang Liu, Alexander J. Mentzer, Helen M. Ginn, et al. (+47)
40 [GO] 2021―Feb―18 The antigenic anatomy of SARS-CoV-2 receptor binding domain Wanwisa Dejnirattisai, Daming Zhou, Helen M. Ginn, Helen M.E. Duyvesteyn, Piyada Supasa, James Brett Case, et al. (+47)
41 [GO] 2021―Feb―17 COVID-19 and the human innate immune system Joachim L. Schultze, Anna C. Aschenbrenner
42 [GO] 2021―Feb―15 Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection Emma S. Winkler, Pavlo Gilchuk, Jinsheng Yu, Adam L. Bailey, Rita E. Chen, Zhenlu Chong, et al. (+14)
43 [GO] 2021―Feb―10 Time-resolved Systems Immunology Reveals a Late Juncture Linked to Fatal COVID-19 Can Liu, Andrew J. Martins, William W. Lau, Nicholas Rachmaninoff, Jinguo Chen, Luisa Imberti, et al. (+34)
44 [GO] 2021―Feb―09 Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection Elizabeth M. Anderson, Eileen C. Goodwin, Anurag Verma, Claudia P. Arevalo, Marcus J. Bolton, Madison E. Weirick, et al. (+32)
45 [GO] 2021―Feb―09 In vivo structural characterization of the SARS-CoV-2 RNA genome identifies host proteins vulnerable to repurposed drugs Lei Sun, Pan Li, Xiaohui Ju, Jian Rao, Wenze Huang, Lili Ren, et al. (+9)
46 [GO] 2021―Feb―05 COVID-19 immune features revealed by a large-scale single cell transcriptome atlas Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, et al. (+84)
47 [GO] 2021―Jan―29 Public health actions to control new SARS-CoV-2 variants Nathan D. Grubaugh, Emma B. Hodcroft, Joseph R. Fauver, Alexandra L. Phelan, Muge Cevik
48 [GO] 2021―Jan―28 Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity Emma C. Thomson, Laura E. Rosen, James G. Shepherd, Roberto Spreafico, Ana da Silva Filipe, Jason A. Wojcechowskyj, et al. (+60)
49 [GO] 2021―Jan―26 Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection Philip J.M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre-Bosquet, Marloes Grobben, Mathieu Claireaux, et al. (+41)
50 [GO] 2021―Jan―14 Messenger RNA vaccines against SARS-CoV-2 Eric J. Topol
51 [GO] 2021―Jan―13 Adaptive immunity to SARS-CoV-2 and COVID-19 Alessandro Sette, Shane Crotty
52 [GO] 2021―Jan―11 Multi-organ Proteomic Landscape of COVID-19 Autopsies Xiu Nie, Liujia Qian, Rui Sun, Bo Huang, Xiaochuan Dong, Qi Xiao, et al. (+45)
53 [GO] 2020―Dec―23 Compromised SARS-CoV-2-specific placental antibody transfer Caroline Atyeo, Krista M. Pullen, Evan A. Bordt, Stephanie Fischinger, John Burke, Ashlin Michell, et al. (+20)
54 [GO] 2020―Dec―17 A Crisp(r) New Perspective on SARS-CoV-2 Biology Adam L. Bailey, Michael S. Diamond
55 [GO] 2020―Dec―16 COVID-19 neutralizing antibodies predict disease severity and survival Wilfredo F. Garcia-Beltran, Evan C. Lam, Michael G. Astudillo, Diane Yang, Tyler E. Miller, Jared Feldman, et al. (+14)
56 [GO] 2020―Dec―10 Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion Alexandra C. Walls, Xiaoli Xiong, Young-Jun Park, M. Alejandra Tortorici, Joost Snijder, Joel Quispe, et al. (+8)
57 [GO] 2020―Dec―10 Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks William M. Schneider, Joseph M. Luna, H.-Heinrich Hoffmann, Francisco J. Sánchez-Rivera, Andrew A. Leal, Alison W. Ashbrook, et al. (+9)
58 [GO] 2020―Dec―10 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young-Jun Park, M. Alejandra Tortorici, Abigail Wall, Andrew T. McGuire, David Veesler
59 [GO] 2020―Dec―09 Genetic screens identify host factors for SARS-CoV-2 and common cold coronaviruses Ruofan Wang, Camille R. Simoneau, Jessie Kulsuptrakul, Mehdi Bouhaddou, Katherine A. Travisano, Jennifer M. Hayashi, et al. (+14)
60 [GO] 2020―Dec―04 Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy Parinaz Fozouni, Sungmin Son, María Díaz de León Derby, Gavin J. Knott, Carley N. Gray, Michael V. D’Ambrosio, et al. (+26)
61 [GO] 2020―Nov―23 Functional SARS-CoV-2-specific immune memory persists after mild COVID-19 Lauren B. Rodda, Jason Netland, Laila Shehata, Kurt B. Pruner, Peter A. Morawski, Christopher D. Thouvenel, et al. (+18)
62 [GO] 2020―Nov―19 Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes Rajendra Karki, Bhesh Raj Sharma, Shraddha Tuladhar, Evan Peter Williams, Lillian Zalduondo, Parimal Samir, et al. (+10)
63 [GO] 2020―Nov―19 Evaluating the effects of SARS-CoV-2 Spike mutation D614G on transmissibility and pathogenicity Erik Volz, Verity Hill, John T. McCrone, Anna Price, David Jorgensen, Áine O’Toole, et al. (+25)
64 [GO] 2020―Nov―14 Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in cap synthesis Liming Yan, Ji Ge, Litao Zheng, Ying Zhang, Yan Gao, Tao Wang, et al. (+12)
65 [GO] 2020―Nov―10 Baricitinib treatment resolves lower airway macrophage inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques Timothy N. Hoang, Maria Pino, Arun K. Boddapati, Elise G. Viox, Carly E. Starke, Amit A. Upadhyay, et al. (+39)
66 [GO] 2020―Nov―05 Case Study: Prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised cancer patient. Victoria A. Avanzato, M. Jeremiah Matson, Stephanie N. Seifert, Rhys Pryce, Brandi N. Williamson, Sarah L. Anzick, et al. (+8)
67 [GO] 2020―Nov―03 Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production Yuezhou Chen, Adam Zuiani, Stephanie Fischinger, Jyotsna Mullur, Caroline Atyeo, Meghan Travers, et al. (+24)
68 [GO] 2020―Nov―03 Compromised humoral functional evolution tracks with SARS-CoV-2 mortality Tomer Zohar, Carolin Loos, Stephanie Fischinger, Caroline Atyeo, Chuangqi Wang, Matthew D. Slein, et al. (+13)
69 [GO] 2020―Oct―31 Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2 Alexandra C. Walls, Brooke Fiala, Alexandra Schäfer, Samuel Wrenn, Minh N. Pham, Michael Murphy, et al. (+36)
70 [GO] 2020―Oct―29 Emerging Pandemic Diseases: How We Got to COVID-19 David M. Morens, Anthony S. Fauci
71 [GO] 2020―Oct―28 Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19 Yapeng Su, Daniel Chen, Dan Yuan, Christopher Lausted, Jongchan Choi, Chengzhen L. Dai, et al. (+49)
72 [GO] 2020―Oct―24 Identification of required host factors for SARS-CoV-2 infection in human cells Zharko Daniloski, Tristan X. Jordan, Hans-Hermann Wessels, Daisy A. Hoagland, Silva Kasela, Mateusz Legut, et al. (+11)
73 [GO] 2020―Oct―20 Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection Jin Wei, Mia Madel Alfajaro, Peter C. DeWeirdt, Ruth E. Hanna, William J. Lu-Culligan, Wesley L. Cai, et al. (+25)
74 [GO] 2020―Oct―15 The Spanish 1918 Flu and the COVID-19 Disease: The Art of Remembering and Foreshadowing Pandemics Joseph L. Goldstein
75 [GO] 2020―Oct―09 Vascular Disease and Thrombosis in SARS-CoV-2 Infected Rhesus Macaques Malika Aid, Kathleen Busman-Sahay, Samuel J. Vidal, Zoltan Maliga, Stephen Bondoc, Carly Starke, et al. (+21)
76 [GO] 2020―Oct―08 SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses Abhik K. Banerjee, Mario R. Blanco, Emily A. Bruce, Drew D. Honson, Linlin M. Chen, Amy Chow, et al. (+16)
77 [GO] 2020―Oct―05 Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19 Benjamin J. Meckiff, Ciro Ramírez-Suástegui, Vicente Fajardo, Serena J. Chee, Anthony Kusnadi, Hayley Simon, et al. (+9)
78 [GO] 2020―Sep―23 A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model Jakob Kreye, S. Momsen Reincke, Hans-Christian Kornau, Elisa Sánchez-Sendin, Victor Max Corman, Hejun Liu, et al. (+38)
79 [GO] 2020―Sep―23 A Mouse-adapted SARS-CoV-2 induces Acute Lung Injury (ALI) and mortality in Standard Laboratory Mice Sarah R. Leist, Kenneth H. Dinnon, Alexandra Schäfer, Longping V. Tse, Kenichi Okuda, Yixuan J. Hou, et al. (+13)
80 [GO] 2020―Sep―17 Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients Christoph Kreer, Matthias Zehner, Timm Weber, Meryem S. Ercanoglu, Lutz Gieselmann, Cornelius Rohde, et al. (+22)
81 [GO] 2020―Sep―16 Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity Carolyn Rydyznski Moderbacher, Sydney I. Ramirez, Jennifer M. Dan, Alba Grifoni, Kathryn M. Hastie, Daniela Weiskopf, et al. (+18)
82 [GO] 2020―Sep―16 Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology Luca Piccoli, Young-Jun Park, M. Alejandra Tortorici, Nadine Czudnochowski, Alexandra C. Walls, Martina Beltramello, et al. (+44)
83 [GO] 2020―Sep―15 Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant Leonid Yurkovetskiy, Xue Wang, Kristen E. Pascal, Christopher Tomkins-Tinch, Thomas P. Nyalile, Yetao Wang, et al. (+16)
84 [GO] 2020―Sep―14 Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy Shuo Du, Yunlong Cao, Qinyu Zhu, Pin Yu, Feifei Qi, Guopeng Wang, et al. (+29)
85 [GO] 2020―Sep―14 SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 Thomas Mandel Clausen, Daniel R. Sandoval, Charlotte B. Spliid, Jessica Pihl, Hailee R. Perrett, Chelsea D. Painter, et al. (+30)
86 [GO] 2020―Sep―06 The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19 Camila Rosat Consiglio, Nicola Cotugno, Fabian Sardh, Christian Pou, Donato Amodio, Lucie Rodriguez, et al. (+17)
87 [GO] 2020―Sep―06 Molecular architecture of the SARS-CoV-2 virus Hangping Yao, Yutong Song, Yong Chen, Nanping Wu, Jialu Xu, Chujie Sun, et al. (+12)
88 [GO] 2020―Sep―04 COVID-19 makes B cells forget, but T cells remember Pablo F. Cañete, Carola G. Vinuesa
89 [GO] 2020―Sep―04 High potency of a bivalent human VH domain in SARS-CoV-2 animal models Wei Li, Alexandra Schäfer, Swarali S. Kulkarni, Xianglei Liu, David R. Martinez, Chuan Chen, et al. (+18)
90 [GO] 2020―Sep―03 Cancer, COVID-19, and antiviral immunity: the CAPTURE study Lewis Au, Laura Amanda Boos, Anthony Swerdlow, Fiona Byrne, Scott T.C. Shepherd, Annika Fendler, Samra Turajlic
91 [GO] 2020―Sep―03 Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography Kang Zhang, Xiaohong Liu, Jun Shen, Zhihuan Li, Ye Sang, Xingwang Wu, et al. (+39)
92 [GO] 2020―Aug―19 Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19 Naoki Kaneko, Hsiao-Hsuan Kuo, Julie Boucau, Jocelyn R. Farmer, Hugues Allard-Chamard, Vinay S. Mahajan, et al. (+99)
93 [GO] 2020―Aug―19 Effects of COVID-19 on the nervous system Costantino Iadecola, Josef Anrather, Hooman Kamel
94 [GO] 2020―Aug―19 A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2 Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev, Julie M. Fox, Brittany K. Smith, Ian B. Harvey, et al. (+25)
95 [GO] 2020―Aug―15 Emerging Pandemic Diseases: How We Got To COVID-19 David M. Morens, Anthony S. Fauci
96 [GO] 2020―Aug―14 Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, Kristoffer Strålin, Jean-Baptiste Gorin, Annika Olsson, et al. (+24)
97 [GO] 2020―Aug―11 Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding Tyler N. Starr, Allison J. Greaney, Sarah K. Hilton, Daniel Ellis, Katharine H.D. Crawford, Adam S. Dingens, et al. (+7)
98 [GO] 2020―Aug―05 Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 Aymeric Silvin, Nicolas Chapuis, Garett Dunsmore, Anne-Gaëlle Goubet, Agathe Dubuisson, Lisa Derosa, et al. (+39)
99 [GO] 2020―Aug―05 Severe COVID-19 is marked by a dysregulated myeloid cell compartment Jonas Schulte-Schrepping, Nico Reusch, Daniela Paclik, Kevin Baßler, Stephan Schlickeiser, Bowen Zhang, et al. (+65)
100 [GO] 2020―Jul―28 Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication-transcription complex James Chen, Brandon Malone, Eliza Llewellyn, Michael Grasso, Patrick M.M. Shelton, Paul Dominic B. Olinares, et al. (+7)
101 [GO] 2020―Jul―23 A thermostable mRNA vaccine against COVID-19 Na-Na Zhang, Xiao-Feng Li, Yong-Qiang Deng, Hui Zhao, Yi-Jiao Huang, Guan Yang, et al. (+25)
102 [GO] 2020―Jul―17 The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, et al. (+14)
103 [GO] 2020―Jul―13 Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients Christoph Kreer, Matthias Zehner, Timm Weber, Meryem S. Ercanoglu, Lutz Gieselmann, Cornelius Rohde, et al. (+22)
104 [GO] 2020―Jul―09 Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks M. Gordon Joyce, Adam K. Wheatley, Kayvon Modjarrad
105 [GO] 2020―Jul―03 Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear Nathan D. Grubaugh, William P. Hanage, Angela L. Rasmussen
106 [GO] 2020―Jul―03 Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus B. Korber, W.M. Fischer, S. Gnanakaran, H. Yoon, J. Theiler, W. Abfalterer, et al. (+33)
107 [GO] 2020―Jun―28 A universal design of betacoronavirus vaccines against COVID-19, MERS and SARS Lianpan Dai, Tianyi Zheng, Kun Xu, Yuxuan Han, Lili Xu, Enqi Huang, et al. (+15)
108 [GO] 2020―Jun―28 The Global Phosphorylation Landscape of SARS-CoV-2 Infection Mehdi Bouhaddou, Danish Memon, Bjoern Meyer, Kris M. White, Veronica V. Rezelj, Miguel C. Marrero, et al. (+72)
109 [GO] 2020―Jun―24 Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies Christopher O. Barnes, Anthony P. West, Kathryn E. Huey-Tubman, Magnus A.G. Hoffmann, Naima G. Sharaf, Pauline R. Hoffman, et al. (+17)
110 [GO] 2020―Jun―10 Generation of a Broadly Useful Model for COVID-19 Pathogenesis Vaccination, and Treatment Jing Sun, Zhen Zhuang, Jian Zheng, Kun Li, Roy Lok-Yin Wong, Donglan Liu, et al. (+31)
111 [GO] 2020―Jun―10 A SARS-CoV-2 infection model in mice demonstrates protection by neutralizing antibodies Ahmed O. Hassan, James Brett Case, Emma S. Winkler, Larissa Thackray, Natasha M. Kafai, Adam L. Bailey, et al. (+16)
112 [GO] 2020―Jun―06 Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2 Hui Wang, Yuntao Zhang, Baoying Huang, Wei Deng, Yaru Quan, Wenling Wang, et al. (+26)
113 [GO] 2020―May―28 Proteomic and Metabolomic Characterization of COVID-19 Patient Sera Bo Shen, Xiao Yi, Yaoting Sun, Xiaojie Bi, Juping Du, Chao Zhang, et al. (+34)
114 [GO] 2020―May―27 Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19 Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya, Kevin J. Wiehe, Barton F. Haynes
115 [GO] 2020―May―27 SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract Yixuan J. Hou, Kenichi Okuda, Caitlin E. Edwards, David R. Martinez, Takanori Asakura, Kenneth H. Dinnon, et al. (+37)
116 [GO] 2020―May―22 Structural basis for RNA replication by the SARS-CoV-2 polymerase Quan Wang, Jiqin Wu, Haofeng Wang, Yan Gao, Qiaojie Liu, An Mu, et al. (+20)
117 [GO] 2020―May―21 Pathogenesis of SARS-CoV-2 in transgenic mice expressing human angiotensin-converting enzyme 2 Ren-Di Jiang, Mei-Qin Liu, Ying Chen, Chao Shan, Yi-Wu Zhou, Xu-Rui Shen, et al. (+14)
118 [GO] 2020―May―20 Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals Alba Grifoni, Daniela Weiskopf, Sydney I. Ramirez, Jose Mateus, Jennifer M. Dan, Carolyn Rydyznski Moderbacher, et al. (+14)
119 [GO] 2020―May―15 Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19 Daniel Blanco-Melo, Benjamin E. Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, et al. (+9)
120 [GO] 2020―May―13 A global effort to define the human genetics of protective immunity to SARS-CoV-2 infection Jean-Laurent Casanova, Helen C. Su
121 [GO] 2020―May―08 Host-viral infection maps reveal signatures of severe COVID-19 patients Pierre Bost, Amir Giladi, Yang Liu, Yanis Bendjelal, Gang Xu, Eyal David, et al. (+9)
122 [GO] 2020―May―07 Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States Joseph R. Fauver, Mary E. Petrone, Emma B. Hodcroft, Kayoko Shioda, Hanna Y. Ehrlich, Alexander G. Watts, et al. (+30)
123 [GO] 2020―May―04 Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements and Prognosis of COVID-19 Pneumonia Using Computed Tomography Kang Zhang, Xiaohong Liu, Jun Shen, Zhihuan Li, Ye Sang, Xingwang Wu, et al. (+39)
124 [GO] 2020―May―04 Trained immunity: a tool for reducing susceptibility and severity of SARS-CoV-2 infection Mihai G. Netea, Evangelos J. Giamarellos-Bourboulis, Jorge Domínguez-Andrés, Nigel Curtis, Reinout van Crevel, Frank L. van de Veerdonk, Marc Bonten
125 [GO] 2020―Apr―30 SnapShot: COVID-19 Blake Oberfeld, Aditya Achanta, Kendall Carpenter, Pamela Chen, Nicole M. Gilette, Pinky Langat, et al. (+5)
126 [GO] 2020―Apr―30 Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China Jing Lu, Louis du Plessis, Zhe Liu, Verity Hill, Min Kang, Huifang Lin, et al. (+35)
127 [GO] 2020―Apr―29 Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza Timothy R. Abbott, Girija Dhamdhere, Yanxia Liu, Xueqiu Lin, Laine Goudy, Leiping Zeng, et al. (+9)
128 [GO] 2020―Apr―27 SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues Carly G.K. Ziegler, Samuel J. Allon, Sarah K. Nyquist, Ian M. Mbano, Vincent N. Miao, Constantine N. Tzouanas, et al. (+59)
129 [GO] 2020―Apr―24 Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 Vanessa Monteil, Hyesoo Kwon, Patricia Prado, Astrid Hagelkrüys, Reiner A. Wimmer, Martin Stahl, et al. (+12)
130 [GO] 2020―Apr―23 The Architecture of SARS-CoV-2 Transcriptome Dongwan Kim, Joo-Yeon Lee, Jeong-Sun Yang, Jun Won Kim, V. Narry Kim, Hyeshik Chang
131 [GO] 2020―Apr―16 COVID-19: Navigating Uncertainties Together
132 [GO] 2020―Apr―09 Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2 Qihui Wang, Yanfang Zhang, Lili Wu, Sheng Niu, Chunli Song, Zengyuan Zhang, et al. (+8)
133 [GO] 2020―Mar―26 A Genomic Perspective on the Origin and Emergence of SARS-CoV-2 Yong-Zhen Zhang, Edward C. Holmes
134 [GO] 2020―Mar―09 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, et al. (+7)
135 [GO] 2020―Mar―09 Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein Alexandra C. Walls, Young-Jun Park, M. Alejandra Tortorici, Abigail Wall, Andrew T. McGuire, David Veesler
136 [GO] 2020―Feb―19 The Novel Coronavirus Outbreak: What We Know and What We Don’t


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.011 sec